Molly E McLaren1, Nicole R Nissim2, Adam J Woods3. 1. Center for Cognitive Aging and Memory, Department of Clinical and Health Psychology, University of Florida, PO Box 100165, Gainesville, FL 32610, USA. Electronic address: memclaren@phhp.ufl.edu. 2. Center for Cognitive Aging and Memory, Department of Clinical and Health Psychology, University of Florida, PO Box 100165, Gainesville, FL 32610, USA; Department of Neuroscience, University of Florida, PO Box 100244, Gainesville, FL 32610, USA. Electronic address: nnissim18@ufl.edu. 3. Center for Cognitive Aging and Memory, Department of Clinical and Health Psychology, University of Florida, PO Box 100165, Gainesville, FL 32610, USA; Department of Neuroscience, University of Florida, PO Box 100244, Gainesville, FL 32610, USA. Electronic address: ajwoods@phhp.ufl.edu.
Abstract
BACKGROUND: There has been increased interest in the potential use of transcranial direct current stimulation (tDCS) as treatment for multiple conditions including depression, pain, and cognitive impairment. However, few studies account for the possible influence of comorbid medications when conducting tDCS research. OBJECTIVE/HYPOTHESIS: This literature review was conducted to examine what is currently known about the impact of medications on tDCS, provide recommendations for future research practices, and highlight areas where more research is needed. METHODS: Key terms were searched in PubMed and Web of Science to identify studies that examine the impact of medication on tDCS effects in adults. Relevant papers' reference lists were also reviewed for thoroughness. Studies examined the effects of medication on 1 mA tDCS delivered to M1 (motor) and orbit/supraorbital (SO) area. All studies measured the effects of tDCS via MEP TMS paradigm. RESULTS: Results of the literature review suggest multiple classes of medications, including sodium and calcium channel blockers, and medications that influence various neurotransmitter systems (GABA, dopamine, serotonin, etc.) may all impact tDCS effects on tissue excitability. CONCLUSIONS: Research to date suggests multiple classes of medications may impact tDCS effects. These results highlight the importance of documenting medication use in research subjects and carefully considering what types of medications should be allowed into tDCS trials. Many questions still remain regarding the exact mechanisms of action for tDCS and how various parameters (medication dosages, tDCS stimulation intensity, etc.) may further impact the effects of medications on tDCS.
BACKGROUND: There has been increased interest in the potential use of transcranial direct current stimulation (tDCS) as treatment for multiple conditions including depression, pain, and cognitive impairment. However, few studies account for the possible influence of comorbid medications when conducting tDCS research. OBJECTIVE/HYPOTHESIS: This literature review was conducted to examine what is currently known about the impact of medications on tDCS, provide recommendations for future research practices, and highlight areas where more research is needed. METHODS: Key terms were searched in PubMed and Web of Science to identify studies that examine the impact of medication on tDCS effects in adults. Relevant papers' reference lists were also reviewed for thoroughness. Studies examined the effects of medication on 1 mA tDCS delivered to M1 (motor) and orbit/supraorbital (SO) area. All studies measured the effects of tDCS via MEP TMS paradigm. RESULTS: Results of the literature review suggest multiple classes of medications, including sodium and calcium channel blockers, and medications that influence various neurotransmitter systems (GABA, dopamine, serotonin, etc.) may all impact tDCS effects on tissue excitability. CONCLUSIONS: Research to date suggests multiple classes of medications may impact tDCS effects. These results highlight the importance of documenting medication use in research subjects and carefully considering what types of medications should be allowed into tDCS trials. Many questions still remain regarding the exact mechanisms of action for tDCS and how various parameters (medication dosages, tDCS stimulation intensity, etc.) may further impact the effects of medications on tDCS.
Authors: Jessica Grundey; Nivethida Thirugnanasambandam; Kim Kaminsky; Anne Drees; Angela C Skwirba; Nicolas Lang; Walter Paulus; Michael A Nitsche Journal: J Neurosci Date: 2012-03-21 Impact factor: 6.167
Authors: Sri Mahavir Agarwal; Anushree Bose; Venkataram Shivakumar; Janardhanan C Narayanaswamy; Harleen Chhabra; Sunil V Kalmady; Shivarama Varambally; Michael A Nitsche; Ganesan Venkatasubramanian; Bangalore N Gangadhar Journal: Psychiatry Res Date: 2015-12-02 Impact factor: 3.222
Authors: Nivethida Thirugnanasambandam; Jessica Grundey; Kim Adam; Anne Drees; Angela C Skwirba; Nicolas Lang; Walter Paulus; Michael A Nitsche Journal: Neuropsychopharmacology Date: 2010-12-15 Impact factor: 7.853
Authors: Michael A Nitsche; Wiebke Jaussi; David Liebetanz; Nicolas Lang; Frithjof Tergau; Walter Paulus Journal: Neuropsychopharmacology Date: 2004-08 Impact factor: 7.853
Authors: Michael A Nitsche; Jessica Grundey; David Liebetanz; Nicolas Lang; Frithjof Tergau; Walter Paulus Journal: Cereb Cortex Date: 2004-05-13 Impact factor: 5.357
Authors: Charlotte J Stagg; Jonathan G Best; Mary C Stephenson; Jacinta O'Shea; Marzena Wylezinska; Z Tamas Kincses; Peter G Morris; Paul M Matthews; Heidi Johansen-Berg Journal: J Neurosci Date: 2009-04-22 Impact factor: 6.167
Authors: Adam J Woods; Ronald Cohen; Michael Marsiske; Gene E Alexander; Sara J Czaja; Samuel Wu Journal: Contemp Clin Trials Date: 2017-12-05 Impact factor: 2.226
Authors: Leandro da Costa Lane Valiengo; Stephan Goerigk; Pedro Caldana Gordon; Frank Padberg; Mauricio Henriques Serpa; Stephanie Koebe; Leonardo Afonso Dos Santos; Roger Alberto Marcos Lovera; Juliana Barbosa de Carvalho; Martinus van de Bilt; Acioly L T Lacerda; Helio Elkis; Wagner Farid Gattaz; Andre R Brunoni Journal: JAMA Psychiatry Date: 2020-02-01 Impact factor: 21.596
Authors: Don Wei; Sherab Tsheringla; James C McPartland; A Z A Stephen Azariah Allsop Journal: Philos Trans R Soc Lond B Biol Sci Date: 2022-07-11 Impact factor: 6.671
Authors: Benjamin M Hampstead; Nathan Mascaro; Stephen Schlaefflin; Arijit Bhaumik; Julia Laing; Scott Peltier; Brian Martis Journal: Int J Psychophysiol Date: 2019-11-26 Impact factor: 2.997
Authors: N Samartin-Veiga; A J González-Villar; M Pidal-Miranda; A Vázquez-Millán; M T Carrillo-de-la-Peña Journal: Qual Life Res Date: 2022-03-01 Impact factor: 3.440
Authors: David J Clark; Sudeshna A Chatterjee; Jared W Skinner; Paige E Lysne; Chanoan Sumonthee; Samuel S Wu; Ronald A Cohen; Dorian K Rose; Adam J Woods Journal: Neuromodulation Date: 2020-08-18